Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)-Reference-Cited by-同舟云学术

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

Published:2020-07 Issue:3 Volume:10 Page:1-10
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Ghofrani Hossein‐Ardeschir¹²,Grünig Ekkehard³,Jansa Pavel⁴,Langleben David⁵,Rosenkranz Stephan⁶,Preston Ioana R.⁷^ORCID,Rahaghi Franck⁸,Sood Namita⁹,Busse Dennis¹⁰,Meier Christian¹¹,Humbert Marc¹²

Affiliation:

1. University of Giessen and Marburg Lung CenterMember of German Center for Lung ResearchGiessenGermany

2. Department of MedicineImperial College LondonLondonUK

3. Center for Pulmonary HypertensionThoraxklinicUniversity Hospital HeidelbergMember of the German Center for Lung Research (DZL)HeidelbergGermany

4. First Faculty of Medicine and General Teaching HospitalCharles UniversityPragueCzech Republic

5. Center for Pulmonary Vascular Disease and Lady Davis InstituteJewish General HospitalMcGill UniversityMontrealQuebecCanada

6. Klinik III für Innere MedizinHerzzentrum der Universität zu KölnKölnGermany

7. Pulmonary, Critical Care and Sleep DivisionTufts Medical CenterTufts University School of MedicineBostonMAUSA

8. Department of Pulmonary and Critical Care MedicineCleveland Clinic FloridaWestonFLUSA

9. The Lung CenterThe Ohio State UniversityColumbusOHUSA

10. Chrestos Concept GmbH & Co. KGEssenGermany

11. Bayer AGBerlinGermany

12. Assistance Publique–Hôpitaux de ParisService de PneumologieHôpital BicêtreUniversité Paris‐SudLaboratoire d'Excellence en Recherche sur le Médicament et Innovation ThérapeutiqueInstitut National de la Santé et de la Recherche Médicale Unité 999Le Kremlin–BicêtreFrance

Funder

Bayer AG

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894020942121

Reference19 articles.

1. Mechanisms of disease: pulmonary arterial hypertension;Schermuly RT;Nat Rev Cardiol,2011

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) International Society for Heart and Lung Transplantation (ISHLT);Galiè N;Eur Respir J,2015

3. The molecular targets of approved treatments for pulmonary arterial hypertension;Humbert M;Thorax,2016